Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis
Diagnostic accuracy
OA: bronze
CC0
⤵ 109 in-corpus citations
AI-generated summary
Plasma miR-17-5p, miR-20a, and miR-22 were significantly down-regulated in women with endometriosis compared to controls, suggesting potential as non-invasive biomarkers.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
STUDY QUESTION: Can plasma microRNAs be used as a non-invasive diagnostic test for the detection of endometriosis?
SUMMARY ANSWER: Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis compared with those without endometriosis in mainland China.
WHAT IS KNOWN ALREADY: There is currently a pressing need to develop a non-invasive diagnostic test for endometriosis. Altered circulating microRNA profiles have already been linked to various disease states.
STUDY DESIGN, SIZE, AND DURATION: This was a prospective laboratory study in a tertiary-referral university hospital in Beijing, PR China, between January 2012 and May 2012. Twenty-three women with histologically proven endometriosis and 23 endometriosis-free controls were enrolled in this study.
PARTICIPANTS/MATERIALS, SETTING, AND METHODS: Laparoscopic inspection of the abdominopelvic cavity was performed for each patient, and peripheral blood samples were collected before laparoscopy. Microarray-based microRNA expression profiling was used to identify differentially expressed microRNAs in plasma samples between women with and without endometriosis, and quantification of selected microRNAs was performed using quantitative RT-PCR.
MAIN RESULTS AND THE ROLE OF CHANCE: Twenty-seven microRNAs were differentially expressed between women with and without endometriosis, of which six microRNAs (miR-15b-5p, miR-17-5p, miR-20a, miR-21, miR-22 and miR-26a) were selected for validation. MiR-17-5p, miR-20a and miR-22 were significantly down-regulated in women with endometriosis compared with controls (P = 0.011, 0.0020 and 0.0002, respectively), yielding an area under the receiver operator characteristics curve of 0.74 [95% confidence interval (CI): 0.58-0.90], 0.79 (95% CI: 0.65-0.93) and 0.85 (95% CI: 0.71-0.98) in discriminating endometriosis from controls, respectively.
LIMITATIONS AND REASONS FOR CAUTION: Our sample size was small and all cases were rAFS stage III-IV, which may limit generalization of plasma microRNAs for early diagnosis of endometriosis. Moreover, only six microRNAs were selected for validation.
WIDER IMPLICATIONS OF THE FINDINGS: Plasma microRNAs provide a promising opportunity for detection of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (64)
- Clinical practice. Endometriosis via openalex
- Coexistence of endometriosis in women with symptomatic leiomyomas via openalex
- Diagnostic value of serum activin A and follistatin levels in women with peritoneal, ovarian and deep infiltrating endometriosis via openalex
- Differential expression of microRNAs between eutopic and ectopic endometrium in ovarian endometriosis via openalex
- Do symptomatic endometriosis and uterine fibroids appear together? via openalex
- ESHRE guideline for the diagnosis and treatment of endometriosis via openalex
- Functional microRNA involved in endometriosis via openalex
- Hypoxia-induced microRNA-20a expression increases ERK phosphorylation and angiogenic gene expression in endometriotic stromal cells via openalex
- Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries via openalex
- Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosis via openalex
- MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis via openalex
- MicroRNA-regulated pathways associated with endometriosis via openalex
- microRNAs expression in endometriosis and their relation to angiogenic factors via openalex
- MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKKβ/NF-κB pathway and reduced interleukin-8 expression via openalex
- Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis via openalex
- Peripheral biomarkers of endometriosis: a systematic review via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres via openalex
- The expression and ovarian steroid regulation of endometrial micro-RNAs via openalex
- The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression via openalex
- The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis via openalex
- The role of microRNAs in endometriosis and associated reproductive conditions via openalex
- Urinary peptide profiling identifies a panel of putative biomarkers for diagnosing and staging endometriosis via openalex
- W2097713515 via openalex
- W2107277218 via openalex
- W2108836814 via openalex
- W2111848990 via openalex
- W2113810141 via openalex
- W2113899452 via openalex
- W2115093090 via openalex
- W18374401 via openalex
- W2120071142 via openalex
- W2125052189 via openalex
- W2135810600 via openalex
- W2139528114 via openalex
- W2146543607 via openalex
- W2161068194 via openalex
- W2163169629 via openalex
- W2166050085 via openalex
- W2170070360 via openalex
- W2171296186 via openalex
- W2119604948 via openalex
- W1963853602 via openalex
- W1991084052 via openalex
- W2005479935 via openalex
- W2006760151 via openalex
- W2007173417 via openalex
- W2014946489 via openalex
- W2017426710 via openalex
- W2025449301 via openalex
- W2027744584 via openalex
- W2032696674 via openalex
- W2037054089 via openalex
- W2047119105 via openalex
- W2050245631 via openalex
- W2055818547 via openalex
- W2060863314 via openalex
- W2064273803 via openalex
- W2065018564 via openalex
- W2066442082 via openalex
- W2071813506 via openalex
- W2093966693 via openalex
- W2094077020 via openalex
- W2097233439 via openalex
Cited by (50)
- Advances in Metabolic Syndrome and Endometriosis: Emerging Insights and Therapeutic Horizons 2026
- Biomarkers of endometriosis 2025
- Diagnostic accuracy of non-coding RNA for detecting endometriosis: A systematic review and meta-analysis 2025
- Identifying serum microRNAs as biomarkers for endometriosis in adolescents and young adults 2025
- Functional biomarkers for endometriosis targeting small RNAs in bacterial extracellular vesicles 2025
- Circulating miRNA as diagnostic tools for gynecological diseases and their applications in biosensor development 2025
- Endometriosis in Adolescence: A Narrative Review of the Psychological and Clinical Implications 2025
- <span data-contrast="auto">Evaluating the Prognostic Potential of CA-125 and miRNA Levels in Endometriosis: A Narrative Review <span data-ccp-props="{"> 2024
- Circulating microRNAs as Non-Invasive Biomarkers in Endometriosis Diagnosis-A Systematic Review 2024
- Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next-generation sequencing data analysis 2024
- MiRNAs related in signaling pathways of women's reproductive diseases: an overview 2024
- Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis 2024
- Identification of a Serum Exosome-Derived lncRNA‒miRNA‒mRNA ceRNA Network in Patients with Endometriosis 2024
- Association of endometriosis with Sjögren's syndrome: Genetic insights (Review) 2024
- Endometriotic lesions and their recurrence: A Study on the mediators of immunoregulatory (TGF-β/miR-20a) and stemness (NANOG/miR-145) 2024
- Diagnostic value of the combination of circulating serum miRNAs and CA125 in endometriosis 2023
- Altered Differential Expression of Genes and microRNAs Related to Adhesion and Apoptosis Pathways in Patients with Different Phenotypes of Endometriosis 2023
- Genetics and genomics of endometriosis☆ 2023
- The Pathological Role of miRNAs in Endometriosis 2023
- TNFα-Induced Altered miRNA Expression Links to NF-κB Signaling Pathway in Endometriosis 2023
- Circulating miR-3613-5p but not miR-125b-5p, miR-199a-3p, and miR-451a are biomarkers of endometriosis 2023
- Identifying a panel of nine genes as novel specific model in endometriosis noninvasive diagnosis 2023
- Comparative Study of Serum miRNA as A Biomarker for Non-Invasive Diagnosis in Suspected Versus Proven Cases of Endometriosis 2023
- Liquid Biopsy in Endometriosis: A Systematic Review 2023
- Endometriosis-associated infertility: From pathophysiology to tailored treatment 2022
- Expressão diferencial de genes e microRNAs relacionados com as vias de adesão e apoptose nos diferentes fenótipos de pacientes com endometriose 2022
- Endometriosis Research: From Bench to Bedside 2022
- Integrated bioinformatic analysis of dysregulated microRNA-mRNA co-expression network in ovarian endometriosis 2022
- Non-invasive diagnosis of endometriosis: Immunologic and genetic markers 2022
- Roles of microRNAs in Regulating Apoptosis in the Pathogenesis of Endometriosis 2022
- Hsa-mir-135a Shows Potential as A Putative Diagnostic Biomarker in Saliva and Plasma for Endometriosis 2022
- Inflammatory MicroRNAs and the Pathophysiology of Endometriosis and Atherosclerosis: Common Pathways and Future Directions Towards Elucidating the Relationship 2022
- Identification of miR-34-3p as a candidate follicular phase serum marker for endometriosis: a pilot study 2022
- Role of serum microRNAs as biomarkers for endometriosis, endometrioid carcinoma of ovary & endometrioid endometrial cancer 2022
- MicroRNAs Dysregulation as Potential Biomarkers for Early Diagnosis of Endometriosis 2022
- Ovarian endometriosis, a precursor of ovarian cancer: Histological aspects, gene expression and microRNA alterations (Review) 2021
- Circulating miRNAs Related to Epithelial-Mesenchymal Transitions (EMT) as the New Molecular Markers in Endometriosis 2021
- Overview of miRNAs for the non-invasive diagnosis of endometriosis: evidence, challenges and strategies. A systematic review 2021
- The Role of miRNAs 340-5p, 92a-3p, and 381-3p in Patients with Endometriosis: A Plasma and Mesenchymal Stem-Like Cell Study 2021
- microRNAs as novel diagnostic biomarkers in endometriosis patients: a systematic review and meta-analysis 2021
- Novel diagnostic options for endometriosis - Based on the glycome and microbiome 2021
- miR-424-5p Combined with miR-17-5p Has High Diagnostic Efficacy for Endometriosis 2021
- Circulating serum miR-200c and miR-34a-5p as diagnostic biomarkers for endometriosis 2021
- A Panel of Plasma miRNAs 199b-3p, 224-5p and Let-7d-3p as Non-Invasive Diagnostic Biomarkers for Endometriosis 2021
- MicroRNA variants in endometriosis and its severity 2021
- Molecular dysregulations underlying the pathogenesis of endometriosis 2021
- A critical appraisal of the circulating levels of differentially expressed microRNA in endometriosis† 2021
- microRNA and Overcoming the Challenges of Their Use in the Diagnosis of Endometriosis 2020
- Endometriosis 2020
- Accurate diagnosis of endometriosis using serum microRNAs 2020
Source provenance
- europepmc
- last seen: 2026-10-15T06:08:49.021275+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:11:10.042802+00:00
License: CC0
· commercial use OK